University of California - Davis Health Oct 2 2025 In a preclinical study, UC Davis Comprehensive Cancer Center scientists developed a highly targeted gene therapy that could revolutionize treatment for cancers linked to a common herpesvirus, with minimal side effects. The novel approach treats Kaposi's sarcoma and related diseases caused by the Kaposi's sarcoma-associated herpesvirus (KSHV). The cancer-causing virus remains a major health issue, especially for people living with HIV/AIDS in